337 research outputs found

    Π‘ΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΠΌΠΎΠ½ΡƒΠΌΠ΅Π½Ρ‚Π° Β«Π’ΠΎΠ·Ρ€ΠΎΠΆΠ΄Π΅Π½ΠΈΠ΅ крымскотатарского Π½Π°Ρ€ΠΎΠ΄Π°Β» ΠΊΠ°ΠΊ ΠΊΡƒΠ»ΡŒΡ‚ΡƒΡ€Π½ΠΎΠ΅ явлСниС Π² ΠΆΠΈΠ·Π½ΠΈ крымского общСства

    Get PDF
    Π’ ΡΡ‚Π°Ρ‚ΡŒΠ΅ Π°Π²Ρ‚ΠΎΡ€ΠΎΠΌ ΠΎΡ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ·ΠΎΠ²Π°Π½ Π³Ρ€Π°Π΄ΠΎΡΡ‚Ρ€ΠΎΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹ΠΉ ΠΎΠ±ΡŠΠ΅ΠΊΡ‚ ΠœΠΎΠ½ΡƒΠΌΠ΅Π½Ρ‚ Β«Π’ΠΎΠ·Ρ€ΠΎΠΆΠ΄Π΅Π½ΠΈΠ΅ крымскотатарского Π½Π°Ρ€ΠΎΠ΄Π°Β» ΠΊΠ°ΠΊ ΠΊΡƒΠ»ΡŒΡ‚ΡƒΡ€Π½ΠΎΠ΅ явлСниС Π² ΠΆΠΈΠ·Π½ΠΈ крымского общСства, ΠΏΡ€ΠΈΠ·Π²Π°Π½Π½ΠΎΠ΅ внСсти Π²ΠΊΠ»Π°Π΄ Π² процСсс воспитания духовности ΠΈ ΠΊΡƒΠ»ΡŒΡ‚ΡƒΡ€Ρ‹ Π² ΠΌΠΎΠ»ΠΎΠ΄Ρ‹Ρ… Π»ΡŽΠ΄ΡΡ….Π£ статті Π°Π²Ρ‚ΠΎΡ€ΠΎΠΌ ΠΎΡ…Π°Ρ€Π°ΠΊΡ‚Π΅Ρ€ΠΈΠ·ΠΎΠ²Π°Π½ΠΎ ΠΌΡ–ΡΡ‚ΠΎΠ±ΡƒΠ΄Ρ–Π²Π΅Π»ΡŒΠ½ΠΈΠΉ об’єкт ΠœΠΎΠ½ΡƒΠΌΠ΅Π½Ρ‚ «ВідродТСння ΠΊΡ€ΠΈΠΌΡΡŒΠΊΠΎΡ‚Π°Ρ‚Π°Ρ€ΡΡŒΠΊΠΎΠ³ΠΎ Π½Π°Ρ€ΠΎΠ΄ΡƒΒ» як ΠΊΡƒΠ»ΡŒΡ‚ΡƒΡ€Π½Π΅ явищС Ρƒ ΠΆΠΈΡ‚Ρ‚Ρ– ΠΊΡ€ΠΈΠΌΡΡŒΠΊΠΎΠ³ΠΎ ΡΡƒΡΠΏΡ–Π»ΡŒΡΡ‚Π²Π°, Ρ‰ΠΎ ΠΏΡ€ΠΈΠ·Π²Π°Π½ΠΈΠ΅ донСсти внСсок Ρƒ процСс виховання духовності Ρ‚Π° ΠΊΡƒΠ»ΡŒΡ‚ΡƒΡ€ΠΈ ΠΌΠΎΠ»ΠΎΠ΄Ρ–.The author describes a monument β€žRebirth of the Crimean Tatars” as a cultural phenomenon in the life of the Crimean society, which can contribute in the process of spiritual and cultural upbringing of young people

    ΠŸΠ°Ρ€Π°Π΄ΠΈΠ³ΠΌΠ° ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π½ΠΎΠ³ΠΎ Ρ€ΠΈΠ·ΠΈΠΊΡƒ Π² систСмі Π½Π°Ρ†Ρ–ΠΎΠ½Π°Π»ΡŒΠ½ΠΎΡ— Π±Π΅Π·ΠΏΠ΅ΠΊΠΈ Π£ΠΊΡ€Π°Ρ—Π½ΠΈ (ΠΏΡ€ΠΈΠΊΠ»Π°Π΄Π½ΠΈΠΉ аспСкт)

    Get PDF
    Π ΠΎΠ·Π³Π»ΡΠ΄Π°Ρ”Ρ‚ΡŒΡΡ загальна модСль систСми Π½Π°Ρ†Ρ–ΠΎΠ½Π°Π»ΡŒΠ½ΠΎΡ— Π±Π΅Π·ΠΏΠ΅ΠΊΠΈ. Π’ΠΈΠ·Π½Π°Ρ‡Π°ΡŽΡ‚ΡŒΡΡ місцС Ρ‚Π° Ρ€ΠΎΠ»ΡŒ ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π½ΠΎΠ³ΠΎ Ρ€ΠΈΠ·ΠΈΠΊΡƒ Π² Ρ„ΡƒΠ½ΠΊΡ†Ρ–ΠΎΠ½ΡƒΠ²Π°Π½Π½Ρ– систСми Π½Π°Ρ†Ρ–ΠΎΠ½Π°Π»ΡŒΠ½ΠΎΡ— Π±Π΅Π·ΠΏΠ΅ΠΊΠΈ. ΠΠ½Π°Π»Ρ–Π·ΡƒΡ”Ρ‚ΡŒΡΡ катСгорія Β«ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π½ΠΈΠΉ Ρ€ΠΈΠ·ΠΈΠΊΒ» Ρ‚Π° ΠΉΠΎΠ³ΠΎ основні складові, ΡƒΠΌΠΎΠ²ΠΈ виникнСння Ρ‚Π° функціонування. ΠŸΡ€ΠΎΠΏΠΎΠ½ΡƒΡŽΡ‚ΡŒΡΡ ΡƒΠΌΠΎΠ²ΠΈ ΠΏΡ€ΠΎΡ‚ΠΈΠ΄Ρ–Ρ— Ρ€ΠΈΠ·ΠΈΠΊΠ°ΠΌ Ρ‚Π° ΠΏΠΎΠ΄Π°Ρ”Ρ‚ΡŒΡΡ модСль зниТСння ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π½ΠΈΡ… Ρ€ΠΈΠ·ΠΈΠΊΡ–Π² Ρƒ систСмі Π½Π°Ρ†Ρ–ΠΎΠ½Π°Π»ΡŒΠ½ΠΎΡ— Π±Π΅Π·ΠΏΠ΅ΠΊΠΈ . ΠšΠ»ΡŽΡ‡ΠΎΠ²Ρ– слова: Π½Π°Ρ†Ρ–ΠΎΠ½Π°Π»ΡŒΠ½Π° Π±Π΅Π·ΠΏΠ΅ΠΊΠ°, ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π½ΠΈΠΉ Ρ€ΠΈΠ·ΠΈΠΊ.РассматриваСтся общая модСль систСмы Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ бСзопасности. ΠžΠΏΡ€Π΅Π΄Π΅Π»ΡΠ΅Ρ‚ΡΡ мСсто ΠΈ Ρ€ΠΎΠ»ΡŒ ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π΅ΡΠΊΠΎΠ³ΠΎ риска ΠΏΡ€ΠΈ Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½ΠΈΡ€ΠΎΠ²Π°Π½ΠΈΠΈ систСмы Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ бСзопасности. АнализируСтся катСгория Β«ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π΅ΡΠΊΠΈΠΉ риск» ΠΈ Π΅Π³ΠΎ основныС ΡΠΎΡΡ‚Π°Π²Π»ΡΡŽΡ‰ΠΈΠ΅, условия возникновСния ΠΈ функционирования. ΠŸΡ€Π΅Π΄Π»Π°Π³Π°ΡŽΡ‚ΡΡ условия противодСйствия рискам ΠΈ подаСтся модСль сниТСния ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π΅ΡΠΊΠΈΡ… рисков Π² систСмС Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ бСзопасности ΠšΠ»ΡŽΡ‡Π΅Π²Ρ‹Π΅ слова: Π½Π°Ρ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½Π°Ρ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ‚ΡŒ, ΡŽΡ€ΠΈΠ΄ΠΈΡ‡Π΅ΡΠΊΠΈΠΉ риск.The problems of forming and development of the system of national safety are examined in the article. The general model of the system of national safety is offered and the role of legal risk is determined in this system. The location and role of legal risk is determined at functioning of the system of national safety. A category is analysed Β«legal riskΒ» and his basic component elements, terms of origin and functioning. The terms of counteraction risks are offered and the model of decline of legal risks is given in the system of national safety. Key words: national safety, legal risk

    Π˜ΡΡ‚ΠΎΡ€ΠΈΡ изучСния ΠΈΠΌΠ΅Π½ ΠΏΡ€ΠΈΠ»Π°Π³Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… Π² крымскотатарском языкС

    Get PDF
    ЦСлью Π΄Π°Π½Π½ΠΎΠΉ ΡΡ‚Π°Ρ‚ΡŒΠΈ являСтся рассмотрСниС стСпСни изучСнности ΠΈΠΌΠ΅Π½ΠΈ ΠΏΡ€ΠΈΠ»Π°Π³Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ Π² крымскотатарском языкС ΠΊΠ°ΠΊ ΡΠ°ΠΌΠΎΡΡ‚ΠΎΡΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ части Ρ€Π΅Ρ‡ΠΈ Π² лингвистичСских Ρ‚Ρ€ΡƒΠ΄Π°Ρ… XIX – XX Π²Π²., Π° Ρ‚Π°ΠΊΠΆΠ΅ Π°Π½Π°Π»ΠΈΠ· основных грамматичСских ΠΊΠ°Ρ‚Π΅Π³ΠΎΡ€ΠΈΠΉ ΠΈΠΌΠ΅Π½ΠΈ ΠΏΡ€ΠΈΠ»Π°Π³Π°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ

    Multiscale simulation of polymer melt viscoelasticity: Expanded-ensemble Monte Carlo coupled with atomistic nonequilibrium molecular dynamics

    Get PDF
    We present a powerful framework for computing the viscoelastic properties of polymer melts based on an efficient coupling of two different atomistic models: the first is represented by the nonequilibrium molecular dynamics method and is considered as the microscale model. The second is represented by a Monte Carlo (MC) method in an expanded statistical ensemble and is free from any long time scale constraints. Guided by recent developments in nonequilibrium thermodynamics, the expanded ensemble incorporates appropriately defined "field" variables driving the corresponding structural variables to beyond equilibrium steady states. The expanded MC is considered as the macroscale solver for the family of all viscoelastic models built on the given structural variable(s). The explicit form of the macroscopic model is not needed; only its structure in the context of the general equation for the nonequilibrium reversible irreversible coupling or generalized bracket formalisms of nonequilibrium thermodynamics is required. We illustrate the method here for the case of unentangled linear polymer melts, for which the appropriate structural variable to consider is the conformation tensor c???. The corresponding Lagrange multiplier is a tensorial field ??. We have been able to compute model-independent values of the tensor ??, which for a wide range of strain rates (covering both the linear and the nonlinear viscoelastic regimes) bring results for the overall polymer conformation from the two models (microscale and macroscale) on top of each other. In a second step, by comparing the computed values of ?? with those suggested by the macroscopic model addressed by the chosen structural variable(s), we can identify shortcomings in the building blocks of the model. How to modify the macroscopic model in order to be consistent with the results of the coupled micro-macro simulations is also discussed. From a theoretical point of view, the present multiscale modeling approach provides a solid framework for the design of improved, more accurate macroscopic models for polymer melts.open151

    VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever

    Get PDF
    Development of effective vaccines against emerging infectious diseases (EID) can take as much or more than a decade to progress from pathogen isolation/identification to clinical approval. As a result, conventional approaches fail to produce field-ready vaccines before the EID has spread extensively. Lassa is a prototypical emerging infectious disease endemic to West Africa for which no successful vaccine is available. We established the VaxCelerate Consortium to address the need for more rapid vaccine development by creating a platform capable of generating and pre-clinically testing a new vaccine against specific pathogen targets in less than 120 d. A self-assembling vaccine is at the core of the approach. It consists of a fusion protein composed of the immunostimulatory Mycobacterium tuberculosis heat shock protein 70 (MtbHSP70) and the biotin binding protein, avidin. Mixing the resulting protein (MAV) with biotinylated pathogen-specific immunogenic peptides yields a self-assembled vaccine (SAV). To meet the time constraint imposed on this project, we used a distributed R&D model involving experts in the fields of protein engineering and production, bioinformatics, peptide synthesis/design and GMP/GLP manufacturing and testing standards. SAV immunogenicity was first tested using H1N1 influenza specific peptides and the entire VaxCelerate process was then tested in a mock live-fire exercise targeting Lassa fever virus. We demonstrated that the Lassa fever vaccine induced significantly increased class II peptide specific interferon-Ξ³ CD4+ T cell responses in HLA-DR3 transgenic mice compared to peptide or MAV alone controls. We thereby demonstrated that our SAV in combination with a distributed development model may facilitate accelerated regulatory review by using an identical design for each vaccine and by applying safety and efficacy assessment tools that are more relevant to human vaccine responses than current animal models

    Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases:Multidisciplinary Consensus Document from the COLLISION Trial Group

    Get PDF
    The guidelines for metastatic colorectal cancer crudely state that the best local treatment should be selected from a 'toolbox' of techniques according to patient- and treatment-related factors. We created an interdisciplinary, consensus-based algorithm with specific resectability and ablatability criteria for the treatment of colorectal liver metastases (CRLM). To pursue consensus, members of the multidisciplinary COLLISION and COLDFIRE trial expert panel employed the RAND appropriateness method (RAM). Statements regarding patient, disease, tumor and treatment characteristics were categorized as appropriate, equipoise or inappropriate. Patients with ECOG≀2, ASA≀3 and Charlson comorbidity index ≀8 should be considered fit for curative-intent local therapy. When easily resectable and/or ablatable (stage IVa), (neo)adjuvant systemic therapy is not indicated. When requiring major hepatectomy (stage IVb), neo-adjuvant systemic therapy is appropriate for early metachronous disease and to reduce procedural risk. To downstage patients (stage IVc), downsizing induction systemic therapy and/or future remnant augmentation is advised. Disease can only be deemed permanently unsuitable for local therapy if downstaging failed (stage IVd). Liver resection remains the gold standard. Thermal ablation is reserved for unresectable CRLM, deep-seated resectable CRLM and can be considered when patients are in poor health. Irreversible electroporation and stereotactic body radiotherapy can be considered for unresectable perihilar and perivascular CRLM 0-5cm. This consensus document provides per-patient and per-tumor resectability and ablatability criteria for the treatment of CRLM. These criteria are intended to aid tumor board discussions, improve consistency when designing prospective trials and advance intersociety communications. Areas where consensus is lacking warrant future comparative studies.</p

    Fundamental limits on quantum dynamics based on entropy change

    Get PDF
    It is well known in the realm of quantum mechanics and information theory that the entropy is non-decreasing for the class of unital physical processes. However, in general, the entropy does not exhibit monotonic behavior. This has restricted the use of entropy change in characterizing evolution processes. Recently, a lower bound on the entropy change was provided in the work of Buscemi, Das, and Wilde [Phys. Rev. A 93(6), 062314 (2016)]. We explore the limit that this bound places on the physical evolution of a quantum system and discuss how these limits can be used as witnesses to characterize quantum dynamics. In particular, we derive a lower limit on the rate of entropy change for memoryless quantum dynamics, and we argue that it provides a witness of non-unitality. This limit on the rate of entropy change leads to definitions of several witnesses for testing memory effects in quantum dynamics. Furthermore, from the aforementioned lower bound on entropy change, we obtain a measure of non-unitarity for unital evolutions

    Impact of Complications After Pancreatoduodenectomy on Mortality, Organ Failure, Hospital Stay, and Readmission Analysis of a Nationwide Audit:Analysis of a Nationwide Audit

    Get PDF
    OBJECTIVE: To quantify the impact of individual complications on mortality, organ failure, hospital stay, and readmission after pancreatoduodenectomy. SUMMARY OF BACKGROUND DATA: An initial complication may provoke a sequence of adverse events potentially leading to mortality after pancreatoduodenectomy. This study was conducted to aid prioritization of quality improvement initiatives. METHODS: Data from consecutive patients undergoing pancreatoduodenectomy (2014-2017) were extracted from the Dutch Pancreatic Cancer Audit. Population attributable fractions (PAF) were calculated for the association of each complication (ie, postoperative pancreatic fistula, postpancreatectomy hemorrhage, bile leakage, delayed gastric emptying, wound infection, and pneumonia) with each unfavorable outcome [ie, in-hospital mortality, organ failure, prolonged hospital stay (>75th percentile), and unplanned readmission), whereas adjusting for confounders and other complications. The PAF represents the proportion of an outcome that could be prevented if a complication would be eliminated completely. RESULTS: Overall, 2620 patients were analyzed. In-hospital mortality occurred in 95 patients (3.6%), organ failure in 198 patients (7.6%), and readmission in 427 patients (16.2%). Postoperative pancreatic fistula and postpancreatectomy hemorrhage had the greatest independent impact on mortality [PAF 25.7% (95% CI 13.4-37.9) and 32.8% (21.9-43.8), respectively] and organ failure [PAF 21.8% (95% CI 12.9-30.6) and 22.1% (15.0-29.1), respectively]. Delayed gastric emptying had the greatest independent impact on prolonged hospital stay [PAF 27.6% (95% CI 23.5-31.8)]. The impact of individual complications on unplanned readmission was smaller than 11%. CONCLUSION: Interventions focusing on postoperative pancreatic fistula and postpancreatectomy hemorrhage may have the greatest impact on in-hospital mortality and organ failure. To prevent prolonged hospital stay, initiatives should in addition focus on delayed gastric emptying

    Care after pancreatic resection according to an algorithm for early detection and minimally invasive management of pancreatic fistula versus current practice (PORSCH-trial):design and rationale of a nationwide stepped-wedge cluster-randomized trial

    Get PDF
    Background: Pancreatic resection is a major abdominal operation with 50% risk of postoperative complications. A common complication is pancreatic fistula, which may have severe clinical consequences such as postoperative bleeding, organ failure and death. The objective of this study is to investigate whether implementation of an algorithm for early detection and minimally invasive management of pancreatic fistula may improve outcomes after pancreatic resection. Methods: This is a nationwide stepped-wedge, cluster-randomized, superiority trial, designed in adherence to the Consolidated Standards of Reporting Trials (CONSORT) guidelines. During a period of 22 months, all Dutch centers performing pancreatic surgery will cross over in a randomized order from current practice to best practice according to the algorithm. This evidence-based and consensus-based algorithm will provide daily multilevel advice on the management of patients after pancreatic resection (i.e. indication for abdominal imaging, antibiotic treatment, percutaneous drainage and removal of abdominal drains). The algorithm is designed to aid early detection and minimally invasive step-up management of postoperative pancreatic fistula. Outcomes of current practice will be compared with outcomes after implementation of the algorithm. The primary outcome is a composite of major complications (i.e. post-pancreatectomy bleeding, new-onset organ failure and death) and will be measured in a sample size of at least 1600 patients undergoing pancreatic resection. Secondary endpoints include the individual components of the primary endpoint and other clinical outcomes, healthcare resource utilization and costs analysis. Follow up will be up to 90 days after pancreatic resection. Discussion: It is hypothesized that a structured nationwide implementation of a dedicated algorithm for early detection and minimally invasive step-up management of postoperative pancreatic fistula will reduce the risk of major complications and death after pancreatic resection, as compared to current practice. Trial registration: Netherlands Trial Register: NL 6671. Registered on 16 December 2017

    Case-only designs for studying the association of antidepressants and hip or femur fracture.

    Get PDF
    The purpose of this study is to evaluate the performance and validity of the case-crossover (CCO) and self-controlled case-series (SCCS) designs when studying the association between hip/femur fracture (HF) and antidepressant (AD) use in general practitioner databases. In addition, comparability with cohort and case-control designs is discussed. Adult patients with HF and who received an AD prescription during 2001-2009 were identified from UK's The Health Improvement Network (THIN) and the Dutch Mondriaan databases. AD exposure was classified into current, recent and past/non-use (reference). In the CCO, for each patient, a case moment (date of HF) and four prior control moments at -91, -182, -273 and -365 days were defined. In SCCS, incidence of HF was compared between exposure states. Conditional logistic regression was used in the CCO and Poisson regression in the SCCS to compute odds ratios and incidence rate ratios, respectively. In CCO, we adjusted for time-varying co-medication and in SCCS for age. Adjusted estimates for the effect of current AD exposure on HF were higher in the CCO (co-medication-adjusted odds ratio, THIN: 2.24, 95% confidence interval [CI]: 2.04-2.47; Mondriaan: 2.57, 95%CI [1.50, 4.43]) than in the SCCS (age-adjusted incidence rate ratio, THIN: 1.41, 95%CI [1.32, 1.49]; Mondriaan: 2.14, 95%CI [1.51, 3.03]). The latter were comparable with the traditional designs. Case-only designs confirmed the association between AD and HF. The CCO design violated assumptions in this study with regard to exchangeability and length of exposure, and transient effects on outcome. The SCCS seems to be an appropriate design for assessing AD-HF association. Copyright Β© 2016 John Wiley &amp; Sons, Ltd
    • …
    corecore